Literature DB >> 2059798

Steroid receptors in breast cancer.

Z Rayter1.   

Abstract

Recent advances in steroid receptor structure and function now indicate that oestrogen binds to the oestrogen receptor (ER) molecule at a specific site, denoted region E. This allows binding of the oestrogen-ER complex to DNA via cysteine residues in region C of the ER molecule, which tetrahedrally co-ordinate zinc. This modulates transcription and stimulates cell growth. A number of newly discovered growth factors are also regulated by ER, as is the progesterone receptor. Steroid receptor concentrations in tissues can now be measured on smaller tissue samples using enzyme immunoassay or on cells obtained by fine needle aspiration using monoclonal antibody technology. The prognostic value of steroid receptor is limited, but still constitutes the best marker for predicting response to endocrine therapy. The role of steroid receptors in selecting patients for adjuvant therapy is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2059798     DOI: 10.1002/bjs.1800780506

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  13 in total

1.  Treating elderly patients with breast cancer.

Authors:  K Dookeran; A Stotter; R Windle; R Walker
Journal:  BMJ       Date:  1992-05-23

2.  Oestrogen receptor beta (ERbeta) polymorphism and its influence on breast cancer risk.

Authors:  D Surekha; K Sailaja; D Nageswara Rao; D Raghunadharao; S Vishnupriya
Journal:  J Genet       Date:  2009-08       Impact factor: 1.166

3.  Association of physical activity with hormone receptor status: the Shanghai Breast Cancer Study.

Authors:  Swann Arp Adams; Charles E Matthews; James R Hebert; Charity G Moore; Joan E Cunningham; Xiou-Oi Shu; Jeanette Fulton; Yutang Gao; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-06       Impact factor: 4.254

4.  Steroid hormone receptors and their clinical significance in cancer.

Authors:  R I Nicholson; R A McClelland; J M Gee
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

5.  Prediction of nodal spread of breast cancer by using artificial neural network-based analyses of S100A4, nm23 and steroid receptor expression.

Authors:  S R Grey; S S Dlay; B E Leone; F Cajone; G V Sherbet
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

6.  Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density.

Authors:  Vilde D Haakensen; Margarethe Biong; Ole Christian Lingjærde; Marit Muri Holmen; Jan Ole Frantzen; Ying Chen; Dina Navjord; Linda Romundstad; Torben Lüders; Ida K Bukholm; Hiroko K Solvang; Vessela N Kristensen; Giske Ursin; Anne-Lise Børresen-Dale; Aslaug Helland
Journal:  Breast Cancer Res       Date:  2010-08-27       Impact factor: 6.466

7.  Polychlorinated biphenyls and breast cancer risk by combined estrogen and progesterone receptor status.

Authors:  Jennifer A Rusiecki; Theodore R Holford; Shelia H Zahm; Tonzhang Zheng
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

Review 8.  Adjuvant chemotherapy for colorectal cancer.

Authors:  Z Rayter; R J Leicester; J L Mansi
Journal:  Ann R Coll Surg Engl       Date:  1995-03       Impact factor: 1.891

9.  PvuII polymorphism of estrogen receptor-α gene in breast cancer.

Authors:  D Surekha; S Vishnupriya; D Nageswara Rao; K Sailaja; D Raghunadharao
Journal:  Indian J Hum Genet       Date:  2007-09

10.  Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women.

Authors:  Carolyn J Crandall; Mary E Sehl; Sybil L Crawford; Ellen B Gold; Laurel A Habel; Lesley M Butler; Maryfran R Sowers; Gail A Greendale; Janet S Sinsheimer
Journal:  Breast Cancer Res       Date:  2009-07-27       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.